Genomic impact of CRISPR immunization against bacteriophages
- PMID:24256225
- DOI: 10.1042/BST20130160
Genomic impact of CRISPR immunization against bacteriophages
Abstract
CRISPR (clustered regularly interspaced short palindromic repeats) together with CAS (RISPR-associated) genes form the CRISPR-Cas immune system, which provides sequence-specific adaptive immunity against foreign genetic elements in bacteria and archaea. Immunity is acquired by the integration of short stretches of invasive DNA as novel 'spacers' into CRISPR loci. Subsequently, these immune markers are transcribed and generate small non-coding interfering RNAs that specifically guide nucleases for sequence-specific cleavage of complementary sequences. Among the four CRISPR-Cas systems present in Streptococcus thermophilus, CRISPR1 and CRISPR3 have the ability to readily acquire new spacers following bacteriophage or plasmid exposure. In order to investigate the impact of building CRISPR-encoded immunity on the host chromosome, we determined the genome sequence of a BIM (bacteriophage-insensitive mutant) derived from the DGCC7710 model organism, after four consecutive rounds of bacteriophage challenge. As expected, active CRISPR loci evolved via polarized addition of several novel spacers following exposure to bacteriophages. Although analysis of the draft genome sequence revealed a variety of SNPs (single nucleotide polymorphisms) and INDELs (insertions/deletions), most of the in silico differences were not validated by Sanger re-sequencing. In addition, two SNPs and two small INDELs were identified and tracked in the intermediate variants. Overall, building CRISPR-encoded immunity does not significantly affect the genome, which allows the maintenance of important functional properties in isogenic CRISPR mutants. This is critical for the development and formulation of sustainable and robust next-generation starter cultures with increased industrial lifespans.
Similar articles
- Adaptation in bacterial CRISPR-Cas immunity can be driven by defective phages.Hynes AP, Villion M, Moineau S.Hynes AP, et al.Nat Commun. 2014 Jul 24;5:4399. doi: 10.1038/ncomms5399.Nat Commun. 2014.PMID:25056268
- Comparative Analysis of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) of Streptococcus thermophilus St-I and its Bacteriophage-Insensitive Mutants (BIM) Derivatives.Li W, Bian X, Evivie SE, Huo GC.Li W, et al.Curr Microbiol. 2016 Sep;73(3):393-400. doi: 10.1007/s00284-016-1076-y. Epub 2016 Jul 5.Curr Microbiol. 2016.PMID:27378131
- The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA.Garneau JE, Dupuis MÈ, Villion M, Romero DA, Barrangou R, Boyaval P, Fremaux C, Horvath P, Magadán AH, Moineau S.Garneau JE, et al.Nature. 2010 Nov 4;468(7320):67-71. doi: 10.1038/nature09523.Nature. 2010.PMID:21048762
- CRISPR-Cas systems and RNA-guided interference.Barrangou R.Barrangou R.Wiley Interdiscip Rev RNA. 2013 May-Jun;4(3):267-78. doi: 10.1002/wrna.1159. Epub 2013 Mar 20.Wiley Interdiscip Rev RNA. 2013.PMID:23520078Review.
- Adaptation in CRISPR-Cas Systems.Sternberg SH, Richter H, Charpentier E, Qimron U.Sternberg SH, et al.Mol Cell. 2016 Mar 17;61(6):797-808. doi: 10.1016/j.molcel.2016.01.030. Epub 2016 Mar 3.Mol Cell. 2016.PMID:26949040Review.
Cited by
- Applications of CRISPR technologies in research and beyond.Barrangou R, Doudna JA.Barrangou R, et al.Nat Biotechnol. 2016;34(9):933-941. doi: 10.1038/nbt.3659. Epub 2016 Sep 8.Nat Biotechnol. 2016.PMID:27606440
- CRISPR Visualizer: rapid identification and visualization of CRISPR loci via an automated high-throughput processing pipeline.Nethery MA, Barrangou R.Nethery MA, et al.RNA Biol. 2019 Apr;16(4):577-584. doi: 10.1080/15476286.2018.1493332. Epub 2018 Aug 21.RNA Biol. 2019.PMID:30130453Free PMC article.
- New Insights into Various Production Characteristics of Streptococcus thermophilus Strains.Cui Y, Xu T, Qu X, Hu T, Jiang X, Zhao C.Cui Y, et al.Int J Mol Sci. 2016 Oct 12;17(10):1701. doi: 10.3390/ijms17101701.Int J Mol Sci. 2016.PMID:27754312Free PMC article.Review.
- There're CRISPRs in My Yogurt: A Discovery-Based CURE at the Intersection of Industrial Food Production and the Human Microbiome.Petrie KL.Petrie KL.Front Microbiol. 2020 Oct 22;11:578737. doi: 10.3389/fmicb.2020.578737. eCollection 2020.Front Microbiol. 2020.PMID:33193202Free PMC article.
- Covalent Modification of Bacteriophage T4 DNA Inhibits CRISPR-Cas9.Bryson AL, Hwang Y, Sherrill-Mix S, Wu GD, Lewis JD, Black L, Clark TA, Bushman FD.Bryson AL, et al.mBio. 2015 Jun 16;6(3):e00648. doi: 10.1128/mBio.00648-15.mBio. 2015.PMID:26081634Free PMC article.
Publication types
MeSH terms
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials